Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Conscious Cogn. 2021 Jun 10;93:103156. doi: 10.1016/j.concog.2021.103156

Table 1:

Demographic information and clinical scores

Control ADHD F Effect Size (95% CI)
n 40 39
Age (years) 28.67 (4.97) 29.71 (5.69) 0.72 0.20 (−1.40 – 3.48)
IQ 116.50 (11.33) 111.44 (14.37) 3.03 0.40 (−10.85 – 0.73)
Sex (male:female) 18:22 20:19 X2=0.31
Education (years) 17.18 (2.67) 15.87 (2.41) 5.18* 0.51 (−2.44 – −0.16)
Sleepiness 1.63 (0.67) 1.92 (0.62) 4.20* 0.46 (0.009–.59)
Inattention Symptoms
ACDS 0.13 (0.52) 5.54 (2.65) 156.17** 2.90 (4.55–6.28)
BAARS (self-report) 0.10 (0.38) 5.26 (2.22) 209.43** 3.30 (4.45–5.87)
BAARS (informant report) 0.51 (1.43) 4.05 (2.78) 49.54** 1.64 (2.54 – 4.54)
Hyperactivity/impulsivity Symptoms
ACDS 0.05 (0.32) 4.16 (2.70) 88.95** 2.19 (3.24 – 4.98)
BAARS (self-report) 0.28 (0.51) 4.15 (2.37) 102.56** 2.31 (3.12 – 4.64)
BAARS (informant report) 0.51 (1.48) 2.84 (2.56) 21.81** 1.09 (1.27 – 3.17)
Other Psychiatric Disorders
Major Depressive Disorder (met criteria:did not meet criteria) 8:32 22:17 X2=11.11**
Generalized Anxiety Disorder (met criteria:did not meet criteria) 1:39 7:32 X2=5.18*
Medication Use
Prescribed Stimulant Medication (yes:no) 0:40 21:18 X2=29.34**
Prescribed SSRI/SNRI (yes:no) 0:40 2:37 X2=2.11
*

p < .05;

**

p < .001

ACDS = Adult ADHD Clinical Diagnostic Scale; BAARS = Barkley Adult ADHD Rating Scale; SSRI = selective serotonin reuptake inhibitor; SNRI = serotonin norepinephrine reuptake inhibitor

All symptom counts are for current symptoms

Sleepiness measured from the Stanford Sleepiness Scale and ranged from 1 (wide awake) to 4 (somewhat foggy)